Ke Huang is a registered foreign lawyer (admitted in New York) of Jingtian & Gongcheng LLP, with over 15 years of legal experience. Ke specializes in capital markets, including the overseas issuance of equity and bonds. Ke is particularly skilled in representing issuers and underwriters in international equity and debt offerings related to 144A and Regulation S in Asian regions, including China, Hong Kong, Singapore, Philippines, Thailand, and Indonesia, covering various locations across Asia.

Ke graduated from Northwestern University Pritzker School of Law with a Juris Doctor degree and is qualified to practise law in New York. His working languages are Mandarin and English.

Representative ECM Deals 

Represented Shenwan Hongyuan Capital (H.K.) Limited and BOCOM International (Asia) Limited as joint sponsors and other underwriters on the initial public offering of shares of Qiniu Limited on the Main Board of the Hong Kong Stock Exchange.

Represented CITIC Securities (Hong Kong) Limited as the sole sponsor and other underwriters on the initial public offering of shares of TYK Medicines, Inc, a Chapter 18A company, on the Main Board of the Hong Kong Stock Exchange.

Represented Flowing Cloud Technology Ltd (the first stock of Metaverse of SEHK) on the initial public offering of shares on the Main Board of the Hong Kong Stock Exchange.

Represented CITIC Securities (Hong Kong) Limited and Huatai Financial Holdings (Hong Kong) Limited as the joint sponsors and other underwriters on the HKD5.941 billion initial public offering of shares of Jinke Smart Services Group Co., Ltd on the Main Board of the Hong Kong Stock Exchange.

Represented Kindstar Globalgene Technology as special US counsel on its HKD2.21 billion initial public offering of shares on the Hong Kong Stock Exchange. 

Represented Aesthetic Medical Intl Holding Ltd on its initial public offering in NASDAQ.

Represented Akeso Biopharma on its initial public offering of shares on the Hong Kong Stock Exchange. 

Represented Shanghai Kindly Medical Instruments CO., Ltd. (currently known as Shanghai INT Medical Instruments Co., Ltd.) on its spin-off from its A share listed company and the initial public offering on the Main Board of the Hong Kong Stock Exchange.

Represented Hua Medicine on its initial public offering of shares  on the Hong Kong Stock Exchange.

Represented Sinopec Engineering (Group) Company Limited, a subsidiary of Sinopec Group, in connection with its US$1.8 billion initial public offering on the Hong Kong Stock Exchange. CLSA Limited, J.P. Morgan and UBS acted as joint sponsors.

Represented the international underwriters in connection with the listing of A+H shares of Agricultural Bank of China Limited on the Shanghai Stock Exchange and Hong Kong Stock Exchange, which was the largest initial public offering at that time.

Representative DCM Deals 

Represented Eastern Air Overseas (Hong Kong) Corporation Limited, a wholly-owned subsidiary of China Eastern Airlines Corporation Limited, on  its issuance of SGD500,000,000 2.00% Credit Enhanced Bonds due 2026. 

Represented Poly Property Group Co., Limited, on its issuance of US$500 million 4.00% Guaranteed Notes due 2025. 

Represented ICBCI, Goldman Sachs, UBS and Bank of America Merrill Lunch as the underwriters to the Industrial and Commercial Bank of China’s issue of the AT1 preference shares in three tranches. This issue is the first Asian AT1 offering in three currencies, the first in euros from an Asian bank and the first Asian AT1 offering in Rule 144A/Reg S format. The RMB tranche is also the first offshore RMB denominated AT1 offering and the largest non-sovereign RMB denominated securities offering as of the time of the issuance.

Represented Goldman Sachs and other international underwriters for Hutchinson Whampoa’s US$3.5 billion dual-tranche bond and Eur1.5 billion concurrent offering.

Represented Bank of China International, Goldman Sachs, JP Morgan and UBS on China National Offshore Oil Corporation’s concurrent offering of U.S. dollar and euro-denominated Notes. The Rule 144A/Reg S US$1.3bn Notes are the first to feature a full guarantee from China and are the first to be eligible for listing in the emerging market bond index. The Reg S EUR500m Notes represent CNOOC’s inaugural Euro denominated debt issuance.

Represented America Merrill Lynch, Goldman Sachs and HSBC on Hutchison Whampoa’s issue of its EUR1.75 billion euro-denominated perpetual capital securities, which was the first Asian borrower to issue a euro-denominated perpetual.

Represented Goldman Sachs on Hutchison Whampoa's issuance of perpetual capital securities, which resulted in the largest US dollar perpetual capital securities offering by an Asian issuer.